<DOC>
	<DOCNO>NCT02986568</DOCNO>
	<brief_summary>The purpose study compare standard treatment fusion ontogenetic surgery ( total mesometrial resection , laterally extend endopelvic resection , peritoneal mesometrial resection ) gynecologic cancer order evaluate treatment response , adverse effect survival .</brief_summary>
	<brief_title>Efficacy Standard Treatment Fusion Ontogenetic Surgery Gynecologic Cancers</brief_title>
	<detailed_description>Fujii method ontogenetic surgery surgical method radical hysterectomy preserve pelvic organ function much possible . Fujii method advantage preserve pelvic autonomic nerve radical resection tissue parametrium . And ontogenetic surgery advantage reduce need radiation therapy radical resection tissue parametrium . This study prospective study fusion ontogenetic surgery advantage Fujji method ontogenetic surgery .</detailed_description>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Uterine Neoplasms</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>Female , Age â‰¥ 20 year Patients primary cervical cancer ( FIGO stage IB1IVA ) Patients primary uterine cancer ( FIGO stage IA , grade 3 , IBIVA ) Patients sign approve informed consent Female , Age &lt; 20 year Patients refuse sign inform consent</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Ontogenetic surgery</keyword>
	<keyword>TMMR</keyword>
	<keyword>PMMR</keyword>
	<keyword>LEER</keyword>
</DOC>